scholarly journals Apnea Monitor based on Bluetooth with Android Interface

Author(s):  
I Dewa Made Wirayuda ◽  
I Dewa Gede Hari Wisana ◽  
Priyambada Cahya Nugraha

Apnea monitor is a device that is used to give a warning if there is stop breathing. Stop breathing while sleeping is one form of obstructive sleep apnea. This cessation of breath cannot be underestimated, this is related to the main risk factors for health implications and increased cardiovascular disease and sudden death. The purpose of this study is to design an apnea monitor with the Android interface. This device allows the users to get how many times sleep apnea happens while sleeping and got data to analysis before continuing with a more expensive and advanced sleep test. This device used a flex sensor to detect the respiration rate, the sensor placed on the abdomen or belly so it can measure expand and deflate while breathing. The microcontroller uses an Arduino chip called AT-Mega328. Bluetooth HC-05 used to send respiration data to Android, MIT app inventor used for the android programmer, and on the android, there are plotting of respiration value and when the device detected apnea so the android also gives a warning to the user. Based on the results of testing and measurement then compare with another device, the results of the average% error were 3.61%. This apnea monitor design is portable but there are needs some improvement by using another sensor for detected respiration and using a module other than Bluetooth.

SLEEP ◽  
2021 ◽  
Vol 44 (4) ◽  
Author(s):  
R Doug McEvoy ◽  
Manuel Sánchez-de-la-Torre ◽  
Yüksel Peker ◽  
Craig S Anderson ◽  
Susan Redline ◽  
...  

2007 ◽  
Vol 293 (4) ◽  
pp. R1666-R1670 ◽  
Author(s):  
Walter T. McNicholas

Considerable evidence is now available of an independent association between obstructive sleep apnea syndrome (OSAS) and cardiovascular disease. The association is particularly strong for systemic arterial hypertension, but there is growing evidence of an association with ischemic heart disease and stroke. The mechanisms underlying cardiovascular disease in patients with OSAS are still poorly understood. However, the pathogenesis is likely to be a multifactorial process involving a diverse range of mechanisms, including sympathetic overactivity, selective activation of inflammatory molecular pathways, endothelial dysfunction, abnormal coagulation, and metabolic dysregulation, the latter particularly involving insulin resistance and disordered lipid metabolism. Therapy with continuous positive airway pressure (CPAP) has been associated with significant benefits to cardiovascular morbidity and mortality, both in short-term studies addressing specific aspects of morbidity, such as hypertension, and more recently in long-term studies that have evaluated major outcomes of cardiovascular morbidity and mortality. However, there is a clear need for further studies evaluating the impact of CPAP therapy on cardiovascular outcomes. Furthermore, studies on the impact of CPAP therapy have provided useful information concerning the role of basic cell and molecular mechanisms in the pathophysiology of OSAS.


2020 ◽  
Author(s):  
Diane C Lim ◽  
Richard J Schwab

As part one of the three chapters on sleep-disordered breathing, this chapter reviews obstructive sleep apnea (OSA) epidemiology, causes, and consequences. When comparing OSA prevalence between 1988 to 1994 and 2007 to 2010, we observe that OSA is rapidly on the rise, paralleling increasing rates in obesity. Global epidemiologic studies indicate that there are differences specific to ethnicity with Asians presenting with OSA at a lower body mass index than Caucasians. We have learned that structural and physiologic factors increase the risk of OSA and both can be influenced by genetics. Structural risk factors include craniofacial bony restriction, changes in fat distribution, and the size of the upper airway muscles. Physiologic risk factors include airway collapsibility, loop gain, pharyngeal muscle responsiveness, and arousal threshold. The consequences of OSA include daytime sleepiness and exacerbation of many underlying diseases. OSA has been associated with cardiovascular diseases including hypertension, coronary heart disease, stroke, atrial fibrillation, and other cardiac arrhythmias; pulmonary hypertension; metabolic disorders such as type 2 diabetes, hypothyroidism, acromegaly, Cushing syndrome, and polycystic ovarian syndrome; mild cognitive impairment or dementia; and cancer. This review contains 4 figures, 1 table and 48 references. Key Words: cardiac consequences, craniofacial bony restriction, epidemiology, fat distribution, metabolic disease, neurodegeneration, obesity, obstructive sleep apnea


Sign in / Sign up

Export Citation Format

Share Document